InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: None

Tuesday, 01/14/2020 4:38:36 AM

Tuesday, January 14, 2020 4:38:36 AM

Post# of 169
I'm no an expert but reading the materials going into the AdComm it looks unlikely an approval.

IPCI studies looks uncomplete (only intravenous route was deeply tested) and their drug doesn't offer any superior element to Others already approved.

Odidi ,,,seems he did it again !

I repeat I am not a technician, but from what I understood the application is lacking those characteristics that would make it a win.
Also I am very disappointed they didn't address properly the oral an intranasal way of abuse.

Back to 0.10 ??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCIF News